Clinical trial
Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional MR Continued Access Study
NCT07227675 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional MR Continued Access Study
- Lead sponsor
- Abbott Medical Devices
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 23, 2017
- Completion date
- March 31, 2024
- Enrollment
- 162 (actual)
- Sites
- 32
Conditions
As the registry lists them; a condition with its own page is linked.
mitral regurgitation, mitral valve regurgitation